Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-19

Clinical Trial Update: Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial exploring proton beam radiation with concurrent chemotherapy and nelfinavir for inoperable stage III non-small cell lung cancer; study terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nelfinavir (nelfinavir)
  • Proton beam radiation

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-10-19